Relapse risk after FLAMSA RIC based allogeneic hematopoietic stem cell transplantation in heavily pretreated AML

Jule Ussmann1,2, Madlen Jentzsch3,4, Sebastian Schwind3,4

  • 1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany. jule.ussmann@medizin.uni-leipzig.de.

Abstract

No abstract available in PubMed .